Skip to main content
. 2013 Jul 3;14(5):635–643. doi: 10.1007/s10162-013-0403-2

FIG. 5.

FIG. 5

LPS treatment causes activation of PVM/Ms. A, B The PVM/Ms are activated by LPS treatment. Double-labeled whole-mounted ampullae, saccule, and utricle show PVM/Ms labeled with antibody for F4/80 also positive for GS-IB4 in the LPS-treated groups. The scale bar is 50 μm. C, Percentage of activated PVM/Ms in ampullae, utricle and saccule" after 50 um.